Necrosis of uninvolved bone marrow following filgrastim administration in a patient with Burkitt lymphoma undergoing chemotherapy

Br J Haematol. 2012 Oct;159(1):2. doi: 10.1111/bjh.12009. Epub 2012 Aug 9.

Authors

Li Ding¹, Ajay Rawal, Sharon Luikart, Punit Wadhwa

Affiliation

¹ Hematology Oncology Section, Department of Internal Medicine, Minneapolis VA Medical Center, University of Minnesota, Minneapolis, MN, USA.

PMID: 22881409
DOI: 10.1111/bjh.12009

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow / drug effects*
Bone Marrow / pathology*
Burkitt Lymphoma / drug therapy*
Burkitt Lymphoma / pathology*
Filgrastim
Granulocyte Colony-Stimulating Factor / administration & dosage
Granulocyte Colony-Stimulating Factor / adverse effects*
Humans
Male
Middle Aged
Necrosis
Recombinant Proteins / administration & dosage
Recombinant Proteins / adverse effects

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim